Article
The CD33 short isoform is a gain-of-function variant that enhances Aβ1-42 phagocytosis in microglia.
Molecular neurodegeneration - 25 Mar 2021
Bhattacherjee Abhishek, Jung Jaesoo, Zia Sameera, Ho Madelene, Eskandari-Sedighi Ghazaleh, St Laurent Chris D, McCord Kelli A, Bains Arjun, Sidhu Gaurav, Sarkar Susmita, Plemel Jason R, Macauley Matthew S
Abstract excerpt
BACKGROUND: CD33 is genetically linked to Alzheimer's disease (AD) susceptibility through differential expression of isoforms in microglia. The role of the human CD33 short isoform (hCD33m), preferentially encoded by an AD-protective CD33 allele (rs12459419T), is unknown. Here, we test whether hCD33m represents a loss-of-function or gain-of-function variant. METHODS: We have developed two models to test the role...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
